SINOVAC BIOTECH LTD.

(SVA)
  Report
Delayed Nasdaq  -  04:00 2019-02-22 pm EST
6.470 USD   -0.31%
06/27Sinovac Biotech Secures Conditional Registration in South Africa for COVID-19 Vaccine
MT
06/25Sinovac's COVID-19 vaccine conditionally registered in South Africa
RE
06/25SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
BU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : China to start giving COVID-19 shots to teenagers this month

07/14/2021 | 03:46am EDT

BEIJING, July 14 (Reuters) - Several areas in China will start vaccinating teenagers this month against COVID-19, state media and local authorities said, as the country steps up its inoculation campaign.

China, which has managed to rein in domestic infections, has administered 1.4 billion vaccine doses, or two-fifths of the global total of 3.47 billion doses.

This month, the southwestern region of Guangxi and the city of Jingmen in the central province of Hubei will start vaccinating those aged between 15 and 17, and children between 12 and 14 in August, state media and local disease control officials said in reports on Tuesday.

By the end of October, authorities there aim to have fully vaccinated all eligible in the age group of 12 to 17.

China has approved two domestically developed vaccines, one produced by Sinovac Biotech and the other produced by a Beijing firm affiliated with Sinopharm, for those aged between three and 17.

The world's most populous country, with a population of 1.4 billion, does not regularly disclose how many people have been fully vaccinated, but late last month a state broadcaster said the nationwide rate had exceeded 40%.

Several local authorities said this month that public places, from supermarkets to train stations, will check vaccination credentials and record personal details of unvaccinated visitors, to nudge more people to get doses.

China is expected to vaccinate at least 70% of target groups by the end of this year, Zeng Yixin, deputy director of the National Health Commission, told the official Xinhua news agency last month, without giving details of the groups. (Reporting by Roxanne Liu and Ryan Woo; Editing by Clarence Fernandez)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
SINOPHARM GROUP CO. LTD. 0.21% 19.02 Delayed Quote.12.15%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
YIXIN GROUP LIMITED -7.83% 1.06 Delayed Quote.-13.11%
All news about SINOVAC BIOTECH LTD.
06/27Sinovac Biotech Secures Conditional Registration in South Africa for COVID-19 Vaccine
MT
06/25Sinovac's COVID-19 vaccine conditionally registered in South Africa
RE
06/25SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
BU
06/25Sinovac Biotech Ltd. Announces South African Health Products Regulatory Authority Grant..
CI
06/09SINOVAC BIOTECH : Polio Vaccine Prequalified by WHO - Form 6-K
PU
06/09Sinovac Biotech Ltd. Polio Vaccine Prequalified by WHO
CI
06/08SINOVAC Polio Vaccine Prequalified by WHO
BU
05/06SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
BU
05/02SINOVAC BIOTECH : Press Release - Form 6-K
PU
04/29SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual R..
BU
More news
Financials (USD)
Sales 2021 19 375 M - -
Net income 2021 8 467 M - -
Net cash 2021 13 270 M - -
P/E ratio 2021 0,09x
Yield 2021 -
Capitalization 642 M 642 M -
EV / Sales 2020 -0,78x
EV / Sales 2021 -0,65x
Nbr of Employees 4 281
Free-Float 67,4%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED-7.45%89 299
SAMSUNG BIOLOGICS CO.,LTD.-13.51%43 398
WUXI BIOLOGICS (CAYMAN) INC.-22.42%38 605
BIOGEN INC.-15.00%29 867
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-8.54%26 513